Found: 7
Select item for more details and to access through your institution.
Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 1, p. 199, doi. 10.1007/s00277-023-05478-x
- By:
- Publication type:
- Article
Increased Student Employment Is Associated with Inferior Biology Exam and Course Performance.
- Published in:
- Journal of College Science Teaching, 2024, v. 53, n. 6, p. 623, doi. 10.1080/0047231X.2024.2388568
- By:
- Publication type:
- Article
Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 497, p. 1, doi. 10.1126/scitranslmed.aav5599
- By:
- Publication type:
- Article
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00382-3
- By:
- Publication type:
- Article
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0233-5
- By:
- Publication type:
- Article
Combating the Negative Exam Score Impact of Online Human Physiology Laboratories via Cognitive and Structural Strategies: A Preliminary Analysis.
- Published in:
- Bioscene, 2021, v. 47, n. 2, p. 25
- By:
- Publication type:
- Article
Molecular classification and identification of an aggressive signature in low‐grade B‐cell lymphomas.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 644, doi. 10.1002/hon.3187
- By:
- Publication type:
- Article